Knowing the action of insulin and that the mainstay of treatment for obesity are diet and exercise, one of the necessary approaches is developing treatment strategies with lowest possible daily insulin dose that would at the same not impair the glycemic control (8, 24, 25, 27). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.